Role of centchroman in regression of mastalgia and fibroadenoma

World Journal of Surgery

Volumn 31, Issue 6, 2007, Pages 1178-1184

  Dhar, Anita ^a   Srivastava, Anurag ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CENTCHROMAN; DANAZOL;

ADOLESCENT; ADULT; ALLERGIC RASH; ARTICLE; BREAST DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DRUG SAFETY; ECHOGRAPHY; FEMALE; FIBROADENOMA; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASTALGIA; MENSTRUAL IRREGULARITY; REMISSION; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; BREAST DISEASES; BREAST NEOPLASMS; CENTCHROMAN; ESTROGEN ANTAGONISTS; FEMALE; FIBROADENOMA; HUMANS; PAIN; PAIN MEASUREMENT; TREATMENT OUTCOME; ULTRASONOGRAPHY, MAMMARY;

EID: 34447104073     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9040-4     Document Type: Article

References (46)

1. Goyal A, Mansel RE, on behalf of the Efamast study Group (2005) A randomized multicenter study of gamolenic acid (Efamast) with and without antioxidant vitamins and minerals in the management of mastalgia. Breast J 11:41-47
2. Roberts MM, Elton RA, Robinson SE, et al. (1987) Consultations for breast disease in general practice and hospital referral patterns. Br J Surg 74:1020-1022
3. Hughes LE, Mansel RE, Webster DJT (2000) Breast pain nodularity. In Hughes LE, Mansell RE, Webster DJT, editors, Benign Disorders and Diseases of the Breast: Concepts and Clinical Management, 2nd Edition, London, W. B. Saunders Company, 95-121
4. Fentiman IS, Caleffi M, Hamed H, et al. (1988) Dosage and duration of tamoxifen for mastalgia. A controlled trial. Br J Surg 75:845-846
5. Preece PE, Richards AR, Owen GM, et al. (1975) Mastalgia and total body water. BMJ iv:498-500
6. Sitruk-Ware R, Sterkers N, Mauvais-Jarvis P (1979) Benign breast disease. 1: Hormonal investigation. Obstet Gynecol 53:457-460
7. Swain MC, Hayward JL, Bulbrool RD (1973) Plasma oestradiol and progesterone in benign breast disease. Eur J Cancer 9:553-556
8. England PC, Skinner LG, Cottrell IM, et al. (1974) Serum oestradiol-17 beta in women with benign and malignant breast disease. Br J Cancer 30:571-576
9. Malarkey WB, Schroeder LL, Stevens VC, et al. (1977) Twenty four-hour preoperative endocrine profiles in women with benign and malignant breast disease. Cancer Res 37:4655-4659
10. Cole EN, Sellwood RA, England PC, et al. (1977) Serum prolactin concentration on benign breast disease throughout the menstrual cycle. Eur J Cancer 13:597-603
11. Peters F, Pickardt CR, Zimmerman G, et al. (1981) PRL, TSH and thyroid hormones in benign breast disease. Klin Wochenschr 59:403-407
12. Kumar S, Mansel RE, Hughes LE, et al. (1984) Prolactin response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease. Cancer 53:1311-1315
13. Khanna AK, Tapodar JK, Khanna HD, et al. (2002) Behaviour of estrogen receptor, histological correlation, and clinical outcome in patients with benign breast disorders. Eur J Surg 168:631-634
14. Horrobin DF, Manku MS (1989) Premenstrual syndrome and premenstrual breast pain: disorders of essential fatty acid metabolism. Prostaglandins Leukot Essent Fatty Acids 37:255-261
15. Gateley CA, Maddox PR, Pritchard GA, et al. (1992) Plasma fatty acid profiles in benign breast disorders. Br J Surg 79:407-409
16. Sharma AK, Mishra SK, Salia M, et al. (1994) Cyclical mastalgia-is it a manifestation of aberration in lipid metabolism? Indian J Physiol Pharmacol 38:267-271
17. Barros AC, Mottola J, Ruiz CA, et al. (1999) Reassurance in the treatment of mastalgia. Breast J 5:162-165
18. Hadi MS (2000) Sports brassiere: is it a solution for mastalgia? Breast J 6:407-409
19. Boyd NF, Maguire V, Shannon P, et al. (1989) A clinical trial of low fat high carbohydrate diet in patients with cyclical mastalgia. Breast Cancer Res Treat 10:117
20. Ernster VL, Mason L, Goodson WH, et al. (1982) Effects of caffeine free diet on benign breast disease: a randomised trial. Surgery 91:263-267
21. Minton JP, Foeking MK, Webster DJT, et al. (1979) Response of fibrocystic disease to caffeine withdrawal and correlation with cyclic nucleotides with breast disease. Am J Obstet Gynecol 135:157
22. Ory H, Cole P, MacMahon B (1976) Oral contraceptives and reduced risk of benign breast diseases. N Engl J Med 294:419-422
23. Colak T, Ipek T, Kanik A, et al. (2003) Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment. J Am Coll Surg 196:525-530
24. Pashby NL, Mansel RE, Hughes LE, et al. (1981) A clinical trial of evening primrose oil in mastalgia. Br J Surg 68:801
25. Blommers J, de Lange-De Klerk ES, Kuik DJ, et al. (2002) Evening primrose oil and fish oil for severe chronic astalgia: a randomized, double-blind, controlled trial. Am J Obstet Gynecol 187:1389-1394
26. Goyal A, Mansel RE, on behalf of the Efamast study Group (2005) A randomized multicenter study of gamolenic acid (Efamast) with and without antioxidant vitamins and minerals in the management of mastalgia. Breast J 11:41-47
27. Greenblatt RB, Dmowske WP, Mhesh VB, et al. (1971) Clinical studies with an antigonadotrophin-Danazol. Fertil Steril 22:102-112
28. Asch RH, Greenblatt RB (1971) The use of an impeded androgen Danazol in the management of benign breast disorders. Am J Obstet Gynecol 127:130-134
29. Mansel RE, Wisbey JR, Hughes LE (1982) Controlled trial of the antigonadotrophin danazol in painful nodular benign breast disease. Lancet 928-931
30. Harrison BJ, Maddox PR, Hughes LE (1989) Maitenance therapy of cyclical mastalgia using low dose Danazol. J R Coll Surg Edinb 34:79-84
31. Hinton CP, Bishop HM, Holliday HW, et al. (1986) A double-blind controlled trial of danazol and bromocriptine in the management of severe cyclical breast pain. Br J Clin Pract 40:326-330
32. Mansel RE, Preece PE, Hughes LE (1978) A double-blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease. Br J Surg 65:724-727
33. Blichert-Tolt M, Anderson AN, Henriksen OB, et al. (1979) Treatment of mastalgia with bromocriptine. A double blind crossover study. BMJ 1:237
34. Durning P, Sellwood RA (1982) Bromocriptine in severe cyclical breast pain. Br J Surg 69:248-249
35. Mansel RE, Dogliotti L (1990) European multicentre trial of bromocriptine in cyclical mastalgia. Lancet 335:190-193
36. Mansel RE (1981) A review of the role of bromocriptine in symptomatic benign breast disease. Res Clin Forum 3:61-63
37. Fentiman IS, Caleffi M, Brame K, et al. (1986) Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet 8376:287-288
38. Mansal E, Goyal A, Preece P, et al. (2004) European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia. Am J Obstet Gynecol 191:1942-1949
39. Lawrence WB, Valerie PJ (1997) Diagnosis of Diseases of the Breast, 1st Edition, Philadelphia, W. B. Saunders Company, 385
40. Dent DM, Cant PJ (1989) Fibroadenoma. World J Surg 13:706-710
41. Vivani RS, Gebrim LH, Baracat EC, De Lima GR (2002) Evaluation of the ultrasonographic volume of breast fibroadenomas in women treated with tamoxifen. Minerva Gynecol 54:531-535
42. Kamboj VP, Ray S, Dhawan BN (1992) Centchroman. Drugs Today 28:227-232
43. Kamboj VP, Kar AB, Ray S, Grover PK, Anand N (1971) Antifertility activity of 3,4-trans-2,2-dimethyl-3-phenyl-4-p(β-pyrrolidinoethoxy)- phenyl-7 methoxychroman. Indian J Exp Biol 9:103-104
44. Kamboj VP, Sing MM, Kar AB (1973) Effect of some non-steroidal antifertility agents on the biochemistry of the uterus and uterine fluids in rats. Indian J Exp Biol 11:479-483
45. Kamboj VP, Setty BS, Chandra H, Roy SK, Kar AB (1977) Biological profile of centchroman - A new post-coital contraceptive. Indian J Exp Biol 15:1144-1150
46. Datta JK, Roy S (1977) Effect of centchroman on morphological and biochemical changes induced by testosterone propionate in uterus of rats. Indian J Exp Biol 15:1157-1158